Sign In
Buy LTRN
$3.40
-0.340 (-9.09%)
At Close: Jun 03, 2026
Earnings Scheduled For July 30, 2020
12:00am, Thursday, 30'th Jul 2020
Companies Reporting Before The Bell
• Mastercard Inc. (NYSE:MA) is expected to report quarterly earnings at $1.16 per share on revenue of $3.23 billion.
• Moody's...
Stocks To Watch: Big Focus On Big Tech
08:26am, Saturday, 25'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Lantern Pharma to Host Second Quarter 2020 Operating and Financial Results Conference Call on July 30, 2020
11:56am, Friday, 24'th Jul 2020
Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development and, identify pat
Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company focused on leveraging artificial intelligence ("A.I."), machine learning and genomic data to streamline the drug development proce
'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st
03:00pm, Thursday, 16'th Jul 2020
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / LD Micro today announced that it will be hosting ten companies over the final two weeks of July, with a group presentation in the morning, followed by pr
Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 450 Million Data Points, Ahead of Schedule, and Accelerates the Company’s Path to 1 Billion Data Points Curated Specifically for Oncology Drug Development and Drug Response Prediction
12:45pm, Monday, 29'th Jun 2020
Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development p
Lantern Pharma Announces Two Presentations at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting
01:23pm, Wednesday, 17'th Jun 2020
Lantern Pharma (LTRN), a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process a
Lantern Pharma Announces Closing of Initial Public Offering
07:53pm, Monday, 15'th Jun 2020
Lantern Pharma Inc. (LTRN) (the “Company”), a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the
The Daily Biotech Pulse: Sorrento Submits EUA Application For Rapid Coronavirus Test, Decision Day For Viela, Lantern Pharma IPO
12:12pm, Thursday, 11'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) * AbbVie Inc (NYSE: ABBV) - announced an oncology pa
